NO20004741D0 - Farmasøytiske blandinger for forlenget peptidfrigjøring og fremstillingsmetode - Google Patents
Farmasøytiske blandinger for forlenget peptidfrigjøring og fremstillingsmetodeInfo
- Publication number
- NO20004741D0 NO20004741D0 NO20004741A NO20004741A NO20004741D0 NO 20004741 D0 NO20004741 D0 NO 20004741D0 NO 20004741 A NO20004741 A NO 20004741A NO 20004741 A NO20004741 A NO 20004741A NO 20004741 D0 NO20004741 D0 NO 20004741D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical compositions
- peptide release
- extended peptide
- extended
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9803667A FR2776520B1 (fr) | 1998-03-25 | 1998-03-25 | Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation |
PCT/FR1999/000667 WO1999048517A1 (fr) | 1998-03-25 | 1999-03-22 | Compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20004741D0 true NO20004741D0 (no) | 2000-09-22 |
NO20004741L NO20004741L (no) | 2000-11-22 |
NO324621B1 NO324621B1 (no) | 2007-11-26 |
Family
ID=9524472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20004741A NO324621B1 (no) | 1998-03-25 | 2000-09-22 | Farmasoytiske blandinger for forlenget peptidfrigjoring |
Country Status (19)
Country | Link |
---|---|
US (1) | US6503534B1 (no) |
EP (1) | EP1066049B1 (no) |
JP (1) | JP4162381B2 (no) |
AR (1) | AR020062A1 (no) |
AT (1) | ATE241377T1 (no) |
AU (1) | AU756148B2 (no) |
CA (1) | CA2324901C (no) |
CZ (1) | CZ298941B6 (no) |
DE (1) | DE69908326T2 (no) |
DK (1) | DK1066049T3 (no) |
ES (1) | ES2200507T3 (no) |
FR (1) | FR2776520B1 (no) |
HU (1) | HU228903B1 (no) |
IL (2) | IL138533A0 (no) |
NO (1) | NO324621B1 (no) |
PL (1) | PL197775B1 (no) |
PT (1) | PT1066049E (no) |
RU (1) | RU2224538C2 (no) |
WO (1) | WO1999048517A1 (no) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0117057D0 (en) * | 2001-07-12 | 2001-09-05 | Ferring Bv | Pharmaceutical composition |
RS52966B (en) * | 2002-09-27 | 2014-02-28 | Zentaris Gmbh | FORM OF THE THERAPEUTIC APPLICATION OF ACTIVE PEPTIDES WITH THE LONG TERM RELEASE OF THE ACTIVE INGREDIENT |
ES2233227T1 (es) * | 2003-03-26 | 2005-06-16 | Teva Pharmaceutical Industries Ltd. | Procedimiento para la preparacion de ingredientes farmaceuticos activos con un area superficial especifica. |
WO2005035717A2 (en) | 2003-10-03 | 2005-04-21 | Thorn Bioscience, Llc | Process for the synchronization of ovulation for timed breeding without heat detection |
US7521527B2 (en) * | 2003-12-16 | 2009-04-21 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | GLP-1 pharmaceutical compositions |
WO2005070444A2 (en) * | 2004-01-13 | 2005-08-04 | Vasogenix Pharmaceuticals, Inc. | Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same |
TW200538148A (en) * | 2004-01-13 | 2005-12-01 | Vasogenix Pharmaceuticals Inc | Methods for treating acute myocardial infarction by administering calcitonin gene related peptide and compositions containing the same |
US7976847B2 (en) * | 2004-01-13 | 2011-07-12 | Vasogenix Pharmaceuticals, Inc. | Controlled release CGRP delivery composition for cardiovascular and renal indications |
US7772182B2 (en) * | 2004-08-05 | 2010-08-10 | Alza Corporation | Stable suspension formulations of erythropoietin receptor agonists |
GB0428151D0 (en) | 2004-12-22 | 2005-01-26 | Novartis Ag | Organic compounds |
GB0511269D0 (en) * | 2005-06-02 | 2005-07-13 | Creative Peptides Sweden Ab | Sustained release preparation of pro-insulin C-peptide |
JP2009502483A (ja) * | 2005-07-28 | 2009-01-29 | グローバル リサーチ テクノロジーズ,エルエルシー | 空気からの二酸化炭素除去 |
GB0517627D0 (en) | 2005-08-30 | 2005-10-05 | Tyco Electronics Ltd Uk | Bus-bar and connector |
US20130172274A1 (en) | 2005-12-20 | 2013-07-04 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
CA2634034A1 (en) | 2005-12-20 | 2007-06-28 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
US8841255B2 (en) | 2005-12-20 | 2014-09-23 | Duke University | Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides |
US20070219811A1 (en) * | 2006-03-16 | 2007-09-20 | Kim John S | Method for using an internet-based CRM application to create an on-line leads marketplace |
AU2007339280B2 (en) * | 2006-12-21 | 2013-12-05 | Stryker Corporation | Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents |
CN101678083A (zh) * | 2007-04-04 | 2010-03-24 | 瑟瑞技术公司 | Ghrh分子的药物制剂 |
TWI442932B (zh) | 2008-02-11 | 2014-07-01 | Ferring Int Ct Sa | 以GnRH拮抗劑治療攝護腺癌的方法 |
EP2926825A1 (en) | 2008-06-27 | 2015-10-07 | Duke University | Therapeutic agents comprising elastin-like peptides |
EP2421545B1 (en) | 2009-04-23 | 2017-12-06 | JBS United Animal Health II LLC | Method and composition for synchronizing time of insemination |
CN105663059A (zh) | 2009-05-01 | 2016-06-15 | 辉凌公司 | 用于治疗***癌的组合物 |
TW201043221A (en) * | 2009-05-06 | 2010-12-16 | Ferring Int Ct Sa | Kit and method for preparation of a Degarelix solution |
US20110039787A1 (en) * | 2009-07-06 | 2011-02-17 | Ferring International Center S.A. | Compositions, kits and methods for treating benign prostate hyperplasia |
SG10201407329RA (en) | 2009-08-14 | 2015-01-29 | Phasebio Pharmaceuticals Inc | Modified vasoactive intestinal peptides |
CN105456206B (zh) * | 2010-01-13 | 2018-12-14 | 益普生制药股份有限公司 | 用于延缓释放生长抑素类似物的药物组合物的制备方法 |
RS55457B1 (sr) | 2010-10-27 | 2017-04-28 | Ferring Bv | Postupak za proizvodnju degareliksa i njegovih intermedijara |
EP2447276A1 (en) | 2010-10-27 | 2012-05-02 | Ferring B.V. | Process for the manufacture of Degarelix and its intermediates |
JO3755B1 (ar) | 2011-01-26 | 2021-01-31 | Ferring Bv | تركيبات تستوستيرون |
US9561262B2 (en) | 2011-06-06 | 2017-02-07 | Phasebio Pharmaceuticals, Inc. | Use of modified vasoactive intestinal peptides in the treatment of hypertension |
DE102011114864A1 (de) | 2011-10-05 | 2013-04-11 | Acino Ag | Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat |
RU2657444C2 (ru) | 2012-06-01 | 2018-06-13 | Ферринг Б.В. | Получение дегареликса |
CN113398243A (zh) | 2012-11-28 | 2021-09-17 | 联合动物健康第二有限责任公司 | 用于同步小母猪的授精时间的方法 |
EP2823808A1 (en) | 2013-07-09 | 2015-01-14 | Ipsen Pharma S.A.S. | Pharmaceutical composition for a sustained release of lanreotide |
TW201605488A (zh) | 2013-10-15 | 2016-02-16 | 大塚製藥股份有限公司 | 用以預防及/或治療多囊腎病之藥物 |
EP2910255A1 (en) * | 2014-02-19 | 2015-08-26 | MedSkin Solutions Dr. Suwelack AG | Methods for the production of biopolymers with defined average molecular weight |
TW201625218A (zh) * | 2014-04-18 | 2016-07-16 | Jbs聯合動物保健有限責任公司 | 製造含gnrh凝膠之方法 |
US11052132B2 (en) | 2014-05-08 | 2021-07-06 | Phasebio Pharmaceuticals, Inc. | Methods and compositions for treating cystic fibrosis |
CN114652817A (zh) | 2015-02-09 | 2022-06-24 | 费斯生物制药公司 | 用于治疗肌肉疾病和病症的方法和组合物 |
WO2020170185A1 (en) * | 2019-02-21 | 2020-08-27 | Dr. Reddy’S Laboratories Limited | Substantially pure lanreotide or its salt & process thereof |
GR1009814B (el) * | 2019-07-29 | 2020-09-11 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα που περιλαμβανει ενα πεπτιδιο αναλογο σωματοστατινης |
CN110577567A (zh) * | 2019-09-03 | 2019-12-17 | 杭州诺泰澳赛诺医药技术开发有限公司 | 一种制备高比表面积活性多肽或蛋白的方法 |
WO2023092148A1 (en) * | 2021-11-22 | 2023-05-25 | SpecGx LLC | Injectable sustained release pharmaceutical composition |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990013285A1 (en) * | 1989-05-01 | 1990-11-15 | Enzytech, Inc. | Process for producing small particles of biologically active molecules |
US5595760A (en) * | 1994-09-02 | 1997-01-21 | Delab | Sustained release of peptides from pharmaceutical compositions |
-
1998
- 1998-03-25 FR FR9803667A patent/FR2776520B1/fr not_active Expired - Lifetime
-
1999
- 1999-03-22 HU HU0101545A patent/HU228903B1/hu unknown
- 1999-03-22 CA CA2324901A patent/CA2324901C/fr not_active Expired - Lifetime
- 1999-03-22 PL PL343005A patent/PL197775B1/pl unknown
- 1999-03-22 DK DK99910418T patent/DK1066049T3/da active
- 1999-03-22 AT AT99910418T patent/ATE241377T1/de active
- 1999-03-22 CZ CZ20003432A patent/CZ298941B6/cs not_active IP Right Cessation
- 1999-03-22 EP EP99910418A patent/EP1066049B1/fr not_active Expired - Lifetime
- 1999-03-22 AU AU29384/99A patent/AU756148B2/en not_active Expired
- 1999-03-22 ES ES99910418T patent/ES2200507T3/es not_active Expired - Lifetime
- 1999-03-22 PT PT99910418T patent/PT1066049E/pt unknown
- 1999-03-22 IL IL13853399A patent/IL138533A0/xx active IP Right Grant
- 1999-03-22 DE DE69908326T patent/DE69908326T2/de not_active Expired - Lifetime
- 1999-03-22 RU RU2000126755/15A patent/RU2224538C2/ru active
- 1999-03-22 US US09/646,519 patent/US6503534B1/en not_active Expired - Lifetime
- 1999-03-22 WO PCT/FR1999/000667 patent/WO1999048517A1/fr active IP Right Grant
- 1999-03-22 JP JP2000537564A patent/JP4162381B2/ja not_active Expired - Lifetime
- 1999-03-23 AR ARP990101275A patent/AR020062A1/es not_active Application Discontinuation
-
2000
- 2000-09-18 IL IL138533A patent/IL138533A/en not_active IP Right Cessation
- 2000-09-22 NO NO20004741A patent/NO324621B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2776520A1 (fr) | 1999-10-01 |
ES2200507T3 (es) | 2004-03-01 |
IL138533A (en) | 2006-12-31 |
IL138533A0 (en) | 2001-10-31 |
AU2938499A (en) | 1999-10-18 |
PT1066049E (pt) | 2003-10-31 |
DE69908326D1 (de) | 2003-07-03 |
ATE241377T1 (de) | 2003-06-15 |
NO20004741L (no) | 2000-11-22 |
WO1999048517A1 (fr) | 1999-09-30 |
PL343005A1 (en) | 2001-07-30 |
AU756148B2 (en) | 2003-01-02 |
HUP0101545A3 (en) | 2001-12-28 |
FR2776520B1 (fr) | 2000-05-05 |
PL197775B1 (pl) | 2008-04-30 |
HUP0101545A1 (hu) | 2001-11-28 |
CZ20003432A3 (cs) | 2001-02-14 |
HU228903B1 (en) | 2013-06-28 |
DE69908326T2 (de) | 2004-03-25 |
NO324621B1 (no) | 2007-11-26 |
AR020062A1 (es) | 2002-04-10 |
JP4162381B2 (ja) | 2008-10-08 |
US6503534B1 (en) | 2003-01-07 |
JP2002507578A (ja) | 2002-03-12 |
EP1066049A1 (fr) | 2001-01-10 |
DK1066049T3 (da) | 2003-09-29 |
EP1066049B1 (fr) | 2003-05-28 |
RU2224538C2 (ru) | 2004-02-27 |
CA2324901C (fr) | 2012-01-24 |
CA2324901A1 (fr) | 1999-09-30 |
CZ298941B6 (cs) | 2008-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20004741D0 (no) | Farmasøytiske blandinger for forlenget peptidfrigjøring og fremstillingsmetode | |
DK0980240T3 (da) | Sammensætninger med lang frigivelse og fremgangsmåde til fremstilling heraf | |
DK1079809T3 (da) | Enterisk overtrukket farmaceutisk sammensætning og fremgangsmåde til fremstilling deraf | |
NO20001409L (no) | Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger | |
NO20016277L (no) | Systemer og fremgangsmåter for aerolisering av farmasöytiske sammensetninger | |
IS5245A (is) | Lyfjablanda úr ómeprasól | |
NO20011613L (no) | Sammensetninger og fremgangsmåte for WT1-spesifikk immunterapi | |
DK1372686T3 (da) | Fremgangsmåder og sammensætninger til peptidsyntese | |
ITMI950529A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
IS5747A (is) | Oxazólidínón afleiður, aðferð fyrir framleiðslu þeirra og lyfjasamsetninga sem innihalda þær | |
EE200100649A (et) | A-beeta peptiidi kompositsioonid ja meetodid nende valmistamiseks | |
NO20004540D0 (no) | Sammensetninger av peptider, formuleringer og anvendelse derav | |
EE200100259A (et) | Moksifloksatsiini farmatseutiline preparaat | |
HUP0105160A3 (en) | Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-betha-cyclodextrin or 2-hydroxypropyl-betha-cyclodextrin and method for its preparation and pharmaceutical compositions containing them | |
HUP9902655A3 (en) | Pharmaceutical composition of hedgehog proteins and use thereof | |
DK0977812T3 (da) | Asfaltsammensætninger og fremgangsmåder til fremstilling deraf | |
GB2343117B (en) | Benzimidazole pharmaceutical composition and process of preparation | |
IL123927A (en) | Propanolamine derivatives processes for their preparation and pharmaceutical composition comprising them | |
EP1181022A4 (en) | MEDICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF | |
DK2017269T3 (da) | Krystallinsk form II af ritonavirindeholdende farmaceutisk sammensætning og fremstilling heraf | |
HUP0101749A3 (en) | Formulations for protection of peg-interferon alpha conjugates and method for preparation such formulations | |
IL148421A0 (en) | Pharmaceutical compositions and methods of using secreted frizzled related protein | |
NO20030156D0 (no) | Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav | |
IS2315B (is) | Nýjar greinóttar setnar amínó afleiður af 3-amínó-1-fenýl-1H[1,2,4]tríasóli, aðferðir til framleiðslu á þeim og lyfjasamsetningar sem innihalda þær | |
PT939083E (pt) | Complexos de ferro-succinilcaseina procedimento para sua preparacao e suas composicoes farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |